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ABSTRACT 
A  glycoprotein immunologically related to plasma cold-insoluble globulin  (CIG) 
and  fetal  skin  fibroblast  fibronectin  has  been  purified  from  second-trimester 
human  amniotic  fluid.  This protein  (amniotic  fluid  fibronectin)  migrated more 
slowly  than  CIG  on  sodium  dodecyl  sulfate  gel  electrophoresis  and  showed 
greater polydispersity which could result, at least in part, from heterogeneity in 
glycosylation.  Cloned  human  amniotic  fluid  epithelioid  and  fibroblastic  cells 
synthesized  and  secreted  a  protein  with  similar  properties  into  the  culture 
medium.  Fibronectin  was  shown  to  be  associated  with  the  pericellular  and 
extracellular  matrix  of  cultured  amniotic  fluid  cells  by  immunofluorescence, 
lactoperoxidase-catalyzed iodination,  and labeling with  ferritin-conjugated  anti- 
bodies. The kinetics of secretion of the protein were consistent with its role as a 
matrix protein. We anticipate that amniotic fluid fibronectin will prove to be the 
same protein which elsewhere in the body is incorporated into connective tissues 
and basement membranes. Amniotic fluid could, therefore, serve as a convenient 
source of in vivo synthesized flbronectin for biological and structural studies. 
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Fibronectin (also known as large external transfor- 
mation-sensitive [LETS] protein [18], cell surface 
protein [CSP]  [43], galactoprotein a  [4], or fibro- 
blast  surface  antigen  [37])  is  a  high  molecular 
weight glycoprotein synthesized by many cells in 
culture and found both in the culture medium and 
in association with the  cell  surface (3,  16).  The 
protein is immunologically related to cold-insolu- 
ble globulin  (CIG),  1 a  disulfide-bonded, dimeric 
1 Abbreviation~ used in this paper: fl-APN, fl-aminopro- 
pionitrile; BSA, bovine serum albumin (fraction V); 
plasma  glycoprotein  with  a  subunit  molecular 
weight of -220,000 (32, 36). However, the rela- 
tion of fibronectin to CIG, at a structural level, is 
not known. 
CIG, cold-insoluble globulin; DMEM, Dulbeceo-Vogt 
modified Eagle's  medium; DTr,  dithiothreitol; FCS, 
fetal  calf  serum; FITC,  fluorescein  isothiocyanate; 
HEPES,  N-2-hydroxyethylpiperazine-N'-2-ethane sul- 
fonic acid; MalNEt, N-ethylmaleimide; PBS, calcium- 
and  magnesium-free  phosphate-buffered  saline; 
PhCH,SOzF,  phenylmethanesulfonyl fluoride; SDS- 
PAGE, sodium dodecyl sulfate-polyacrylamide  gel elec- 
trophoresis; Tris-saline, 0.15 M NaC1, 0.05 M Tris-HCl, 
pH 7.5. 
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bronectin and CIG have been found in basement 
membranes and in the  extracellular matrix of a 
number of different tissues (25). Chen et al. (5) 
described the presence, in human amniotic fluid, 
of a high molecular weight protein thought to be 
CIG  (5).  The  observed  enrichment of  CIG  in 
amniotic  fluid  relative  to  fetal  and  maternal 
plasma,  1.2%  of total protein as compared with 
0.2 and 0.3%, respectively, together with the high 
molecular weight of this protein, led the authors 
to suggest that amniotic fluid CIG was not derived 
from plasma but was synthesized by fetal amniotic 
tissues or possibly by amniotic fluid cells. 
There are at least three phenotypically distinct 
cell types that can be cloned from second-trimes- 
ter amniotic fluid and subsequently propagated in 
culture  (13).  These  have  been designated as  E 
(epithelial  ceils),  AF  (ceils  with  epithelioid 
morphology and the predominating clonable cell 
type  in amniotic fluid), and F  (cells with  fibro- 
blastic morphology and the  least frequently iso- 
lated  cell  type).  These  cells  have  been  distin- 
guished on the  basis of their clonal and cellular 
morphology (13),  growth  potential under speci- 
fied  conditions of culture  (13),  and  to  a  lesser 
degree by their patterns of secreted proteins (30, 
34). 
We  have  studied  these  cell  types,  and  cells 
explanted from amnion, with particular attention 
to the synthesis and accumulation of a  CIG-like 
protein in culture. In this paper we document the 
presence, in second-trimester amniotic fluid, of a 
high  molecular weight glycoprotein that is recog- 
nized by antibodies to plasma CIG and fibroblast 
fibronectin, and we describe its quantitation, pu- 
rification, and  preliminary characterization.  We 
also  present  the  results  of  experiments  which 
demonstrate  that  amniotic fluid cells  synthesize 
and accumulate fibronectin in culture. 
MATERIALS  AND  METHODS 
Powdered  Dulbecco-Vogt  modified  Eagle's  medium 
(DMEM), penicillin G, and streptomycin sulfate were 
purchased from  Grand Island Biological Co.,  Grand 
Island, N.Y.; fetal calf serum (FCS) from Irvine Scien- 
tific Sales Co., Inc., Irvine, Calif.; trypsin (1:250) from 
ICN  Pharmaceuticals Inc., Cleveland,  Ohio;  trypsin- 
TPCK,  collagenase, lactoperoxidase, and glucose oxi- 
dase from Worthington Biochemical Corp.,  Freehold, 
N.J.;  pepstatin A from the Protein Research Founda- 
tion,  Japan;  trasylol from Calbiochem, San  Diego, 
Calif.; bovine serum albumin (BSA) and rabbit immuno- 
globulin (IgG) from Miles Laboratories Inc.,  Elkhart, 
Ind. The following  radiochemicals  were purchased from 
New  England  Nuclear,  Boston,  Mass.: L-[2,3-3H]  - 
proline  (35  Ci/mmol),  L-[3,5-3H]tyrosine (53.6  Ci/ 
mmol), L-Jail]amino acid mixture, ~[6-aH(N)]glucosa  - 
mine hydrochloride (29 Ci/mmol), Nal~SI (17 Ci/mg), 
L-[U-14C]proline (225 mCi/mmol), o-[2-aH]mannose (2 
mCi/mmol) was purchased from Amersham/Searle Co., 
Arlington  Heights, Ill.  Ferritin-conjugated goat  anti- 
rabbit  IgG  was  obtained  as  a  gift from Dr.  S.  J. 
Singer and Dr. J. F. Ash. All other antibodies, except 
for anti-CIG, anti-fibronectin, and sheep anti-rabbit IgG 
were  obtained  from  Behring  Diagnostics,  American 
Hoechst Corp., Somerville, N.J. 
Cell Isolation and Culture 
Cloned and mass-cultured amniotic fluid cells were 
isolated from second-trimester amniotic fluid essentially 
as described by Hoehn et al. (13). Cells were collected 
from 1-3 ml of fluid by centrifugation at 350 g for 5 
min, resuspended in Weymouth's medium supplemented 
with  16%  heat-inactivated  FCS,  2  mM  glutamine, 
0.055%  sodium pyruvate,  non-essential amino acids, 
and 100 U/ml of penicillin G, and transferred to 35-mm 
Coming culture plates (Coming Glass Works, Coming, 
N.Y.). 
Plates were screened for clones after 2-3 wk by light 
microscopy. The majority of plates contained fewer than 
two clones. Cell types were identified on the basis of 
cellular and clonal morphology, as described by Hoehn 
et al. (13). Cells with atypical or intermediate morphol- 
ogies were not  used  for  analytical studies.  Actively 
proliferating E,  AF,  or  F  clones,  containing several 
hundred cells, were harvested by trypsinization of the 
entire plate or after isolation of the clone with stainless 
steel wells. For subculture, clones were rapidly washed 
with 0.02%  EDTA, dissociated with a  1:1 mixture of 
EDTA and trypsin (0.25%),  and transferred to 60-mm 
plates. Thereafter,  the  cells were cultured in DMEM 
supplemented with 27 mM NaHCO3, 15 mM N-2-hy- 
droxyethylpiperazine-N'-2-ethane  sulfonic  acid (HEPES), 
2 mM glutamine, 100 U/ml of penicillin, 100/zg/ml of 
streptomycin sulfate, and 16% FCS. Near confluence, 
the cells were passaged to  100-mm plates and subse- 
quently subcultured and split at a ratio of 1:2. Cells were 
intermittently screened for mycoplasma by electron mi- 
croscopy. 
Handling of  Amniotic Fluid 
Amniotic fluids, obtained from second-trimester di- 
agnostic amniocentesis or at hysterotomy, were spun at 
400 g for 5-10 rain to remove cells and debris. Speci- 
mens with evidence of erythrocyte contamination were 
discarded. Protease inhibitors (0.2 mM PhCH2SO2F, 10 
mM MalNEt,  0.1  mM o-phenanthroline)  and 0.01% 
sodium azide were added, and the 400-g supernate was 
further clarified by centrifugation and partially purified 
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Pellets  were  dissolved  in  phosphate-buffered  saline 
(PBS) or Tris-saline containing  PhCH~SO2F and dialyzed 
against  chromatography  buffer  or  1  mM  NH4HCOa 
before lyophilization. 
Preparation of CIG 
CIG was  prepared  from  cryoprecipitates  of human 
plasma by modifications of the method of Mosseson and 
Umfleet (32).  The method  will  be described  in detail 
elsewhere,  z Briefly, the procedure involved adsorption 
on  a  tricalcium  citrate-cellulose column,  precipitation 
with 2.1  M glycine, and chromatography on O-(diethyl- 
aminoethyl)cellulose  (DEAE-cellulose) and  Biorex-70 
(BioRad Lab., Richmond, Calif.). CIG was obtained in 
~10%  yield from  plasma  and  was  electrophoretically 
pure.  CIG  prepared  in  this  way  gave  no  detectable 
immune  precipitation  with  antibodies  to  ct-2-macro- 
globulin, factor VIII, fibrinogen, IgG, IgM, or human 
serum and co-migrated with CIG purified from plasma 
by affinity chromatography on anti-fibronectin-Sepharose 
or  gelatin-Sepharose  (8)  in  the  presence  of  protease 
inhibitors. 
Metabolic Labeling 
Labeling  and  pulse-chase  experiments  were  per- 
formed using confluent cultures of E, AF, and F  cells 
(transfer  2-3).  For  amino  acid  incorporation  experi- 
ments,  DMEM  was  supplemented  with  50  #g/ml  of 
sodium  ascorbate,  100  /zg/ml of fl-aminopropionitrile 
(fl-APN), 2 mM glutamine, and penicillin-streptomycin. 
The amino acid used for labeling was omitted from the 
medium,  except  in  experiments  using  3H-amino  acid 
mixtures, for which  1/10 of the normal concentration of 
all  amino  acids  was  included.  For  studies  involving 
incorporation of sugars,  the cells were labeled in medium 
with  a  glucose  concentration  of  50  mg/l  and  supple- 
mented with 1.1  g/l of sodium pyruvate (24). Cultures 
were preincubated for 30 min and labeled for 12-24 h 
under conditions yielding linear incorporation of isotope 
in the medium compartment. 
After labeling, the medium and the first wash  of the 
cell  layer  were  harvested  into  inhibitors  (0.2  mM 
PhCH2SO~F,  10 mM MalNEt, 0.02 M EDTA) at 4~ 
and centrifuged at 400g for 10 rain. The cell layers were 
washed  three  times  with  PBS  containing  0.2  mM 
PhCH~SO2F and scraped into 0.5 N NH4OH containing 
PhCH2SO2F  at  0~176  The cells were sonicated,  and 
aliquots of the sonicate were removed for protein deter- 
mination by the method of Lowry et al. (26). After the 
addition of 10 ~g/ml of pepstatin A, the proteins of the 
medium and the cell layer were separately precipitated 
by the addition of 50% TCA to a final concentration of 
10% and collected by centrifugation at 38,000 g for 20 
Balian, G., E. Crouch, E. M~ Click, and P. Bornstein. 
Manuscript in preparation. 
min at 0~176  The pellets were washed with 5% TCA 
and  dehydrated  by  successive  washes  with  cold  95% 
ethanol and absolute diethyl ether. For immune precipi- 
tation experiments, the medium was dialyzed, after the 
addition of inhibitors, into Tris-saline containing 0.2 mM 
PhCH2SO2F  at 4*(2. For pulse-chase experiments, cells 
were preincubated for 1 h, pulsed with isotope for 15 or 
30  min, washed  three  times with whole medium, and 
chased  in  medium containing the omitted amino acid. 
For double-labeling experiments, cells were labeled for 
24 h with 25/.rCi/plate of tritiated sugar and 5/.tCi/plate 
of p4C]proline. 
Preparation of Antibodies 
Antibodies to CIG were  prepared  in  rabbits,  using 
highly purified CIG as antigen. For preparation of anti- 
fibronectin  antibodies,  mass  cultures  of  human  skin 
fibroblasts in roller bottles were thoroughly washed to 
remove  serum  and  incubated  for  24  h  in  serum-free 
medium.  Ascorbate  was  omitted  to  reduce  collagen 
secretion and  increase the proportion of fibronectin in 
the  culture  medium.  The  medium was  harvested  into 
inhibitors and precipitated by the addition of 20%  (wt/ 
vol) ammonium sulfate at 0~  The pellet was suspended 
in 1 M NaCI, 0,05 M Tris-HCI, pH 7.5, dialyzed against 
1 mM NH4HCO3 and lyophilized. -6 mg of protein was 
loaded on a preparative slab gel (double thickness with 
3 % stacking gel and 5 % separating gel) and electropho- 
resed  as  described  below.  The  fibronectin  band  was 
sliced from the gel, pulverized in PBS, and added to an 
equal volume of Freund's complete adjuvant for immu- 
nization of rabbits. 
Antisera  were  routinely  precipitated  by  33%  satu- 
rated ammonium sulfate at room temperature and redis- 
solved  in  PBS  at  one-half  the  original  volume.  The 
specificity  of  the  antibodies  was  confirmed  by  SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) of im- 
mune precipitates of radioactive medium and cell layer 
proteins,  as well as by  immunodiffusion  and  immune 
electrophoresis  against  purified  CIG,  flbrinogen,  and 
human plasma. 
Radial Immunodiffusion and 
Immune Electrophoresis 
Radial single immunodiffusion (28) was employed for 
quantitation of CIG and fibronectin. Microradial immu- 
nodiffusion and immune electrophoresis were performed 
using conventional techniques (10). 
Radioimmunoassays 
For  the  immune  titration  of proteins  cross-reacting 
with  antibodies  to CIG,  radiolabeled medium was  di- 
alyzed extensively against Tris-saline. -5,000 cpm were 
added to 1.5-ml microfuge tubes (Beckman Instruments, 
Inc., Palo Alto, Calif.) containing 0.05 ml of 1% BSA. 
The  sample  was  then  incubated  for  30  min  at  room 
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required, with 1% BSA in Tris-saline, pH 7.5.  Before 
adding sheep anti-rabbit IgG serum,  100  bd of rabbit 
IgG (2 mg/ml of Tris-saline, pH 7.5) was added to each 
tube to serve as carrier. 200/.d of the second antiserum 
was then added and samples were incubated for 1-2 h at 
room  temperature  and  then  overnight  at  4~  The 
precipitate was collected at 10,000 g in a microfuge tube 
and washed three times with Tris-saline, and radioactiv- 
ity was measured by liquid scintillation counting. Back- 
grounds with control sera were <5% of the total radio- 
activity. Precipitation of radiolabel could be completely 
inhibited by the  addition of nonradioactive CIG.  The 
specificity  of the precipitation was also verified by SDS- 
PAGE of immune precipitates. 
The amount of CIG reactive-protein in amniotic fluid 
and culture medium was estimated using a radioimmune 
inhibition assay. CIG was iodinated by a modification of 
the Chloramine-T method as described by Hunter and 
Greenwood  (14).  No  change  in  the  electrophoretic 
mobility of the protein was noted after this procedure. 
-40,000 cpm of [Iz~I]CIG in 1% BSA was first reacted 
with increasing concentrations of anti-CIG and precipi- 
tated, after the addition of carrier rabbit IgG, with sheep 
anti-rabbit IgG antiserum. 95 % of freshly iodinated CIG 
was precipitable by this double-antibody procedure with 
a background of -1.5% in the presence of control sera. 
The dilution of anti-CIG serum corresponding to -75% 
of maximal precipitation was used in the inhibition assay. 
In a  typical assay,  100 p.l of 1% BSA, 100 p.l of anti- 
CIG serum diluted as required with normal rabbit IgG 
in  Tris-saline,  and  an  appropriate  volume  of  FCS  to 
neutralize  antibodies  cross-reactive  with  bovine  CIG 
were added to microfuge tubes and incubated for 30 min 
at room temperature. 100 t~l of unlabeled CIG, culture 
medium, or  amniotic fluid was  added  and' allowed to 
incubate for an additional 30 min. At this time, 40,000 
cpm of freshly iodinated CIG was added to each tube, 
and the solutions were incubated for 30 min, followed 
by precipitation with 200  ~tl of sheep anti-rabbit lgG 
antiserum. The pellets were washed and the radioactivity 
was measured in a gamma counter. Background precip- 
itation was -1%.  The amount of protein reacting with 
antibodies  to  CIG  was  obtained  by  reference  to  a 
standard inhibition curve (Fig. 1). 
Affinity Chromatography 
CIG,  antibodies to CIG  and fibronectin, and dena- 
tured type I rat skin collagen were coupled to Sepharose 
CL4B by the method of March et al. (29).  2-3 mg of 
protein  was  coupled  to  1  ml  of  packed  gel  with  an 
efficiency  of  70-80%.  Samples  were  applied  to  the 
antibody and CIG columns  in PBS,  eluted with PBS, 
and  affinity-purified proteins were  eluted  with 0.1  M 
glycine-HC1,  pH  2.8,  or  3  M  NaSCN.  Samples were 
eluted from gelatin-Sepharose with 3 M urea. 
SDS-PA GE and Fluorescence 
Autoradiography 
Proteins were examined by SDS-PAGE on discontin- 
uous methylenebisacrylamide slab gels containing 0.5 M 
deionized urea. A  3% stacking gel was used with 5, 6, 
or  7%  separating gels.  Improved separation  of lower 
molecular  weight  proteins  was  achieved  by  using  a 
composite  gel  in  which  the  lower  3  cm  was  a  I0% 
separating gel. The details of the electrophoretic proce- 
dure  and of the fluorescence autoradiography are  de- 
scribed  in  a  recent  report  from  this  laboratory  (7). 
Molecular weights were  estimated using the following 
standards: myosin (200,000); ~galactosidasc (130,000); 
phosphorylase (98,000); BSA (68,000); actin (45,000). 
Lactoperoxidase-catalyzed iodination 
Iodination  was  performed,  as  described  by  Hynes 
(15), on monolayers of cells cultured for -72 h. 
Immunofluorescence Microscopy 
Cells were  grown on cover slips and treated as de- 
scribed by Bornstein and Ash (2) with minor modifica- 
tions. After washing, the cells were exposed sequentially 
to anti-CIG or anti-fibronectin IgG (affinity purified on 
ClG-Sepharose), 2% paraformaldehyde in PBS and/or 
acetone  at  -20~  and  fluorescein  isothiocyanate 
(FITC)-conjugated goat anti-rabbit IgG. Cells were ex- 
amined with a Zeiss photomicroscope through a 53 x  oil 
immersion lens,  using the  recommended filtration for 
FITC fluorescence. 
Ferritin Labeling and Electron Microscopy 
Near-confluent AF cells were labeled in 35-ram Corn- 
ing plates 1 wk after subculture. After thorough washing, 
cells were exposed sequentially to affinity purified anti- 
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FIGURE  1  Standard radioimmune inhibition curve. In- 
creasing quantities of unlabeled CIG were used to inhibit 
the  precipitation  of  [lmI]CIG  by  anti-CIG  IgG  in  a 
double-antibody assay (see Materials and Methods).  1 
p.l corresponded to 1.44 t~g of CIG using an absorbance 
coefficient (E|~m)  at 280 nm of 13 (32). 
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conjugated goat  anti-rabbit IgG  (23).  After labeling, 
cultures were fixed in situ with half-strength Karnovsky's 
fixative  (21) for 2  h at room temperature, rinsed with 
0.1 M sodium cacodylate  buffer, pH 7.4, and postfixed 
in 1% OsO4 in distilled water for an additional hour at 
room temperature.  The  cultures were  washed  several 
times with  the  0.1%  aqueous uranyl acetate  solution 
used for en bloc staining. The cultures were then dehy- 
drated with colored alcohols (0.1% toluidine blue) (11), 
embedded in Epon (27), and placed in a 60"C oven to 
polymerize for 12 h. The soft, embedded cultures were 
peeled out of cracked culture dishes and returned to the 
60"C oven for an additional 24 h. Thin sections were cut 
en fr~e and perpendicular to the plane of the cell layer 
and stained with uranyl acetate and lead citrate (35). All 
sections were examined with a Philips 201 transmission 
electron microscope. 
RESULTS 
Amniotic Fluid Fibronectin 
Second-trimester amniotic fluid contains a  pro- 
tein  that  is  recognized  by  antibodies to  plasma 
CIG. Radial immunodiffusion of whole or ammo- 
nium  sulfate-precipitated  amniotic  fluid  against 
rabbit anti-human plasma CIG gave a  single line 
of fusion with plasma CIG (Fig. 2). The immuno- 
reactive material yielded a single arc and was seen 
to co-migrate with CIG in immune eleetrophoresis 
(data not shown). 
Flrun~ 2  Radial  immunodiffusion.  The  reactants 
were diffused through 1.5% agarose in PBS. After 24 h, 
the gel was washed and the precipitin lines were stained 
with 0.1% amido black in 7% acetic acid.A-CIG,  rabbit 
anti-human  plasma CIG; MED, AF cell culture medium; 
FLUID, whole amniotic fluid; 20% (NH~)2S04, 20% 
ammonium sulfate  (wt/vol)  precipitate of amniotic fluid 
in PBS. The culture medium was harvested after  12-h 
incubation in  the  absence  of serum,  dialyzed against 
PBS, and concentrated 50-fold by filtration on an Ami- 
con B-15 membrane (Amicon Corp., Lexington, Mass.). 
FtrugE  3  Affinity chromatography of amniotic fluid 
fibronectin on anti-fibronectin-Sepharose. 2 ml of am- 
niotic fluid was applied to the column (10 ml) in PBS 
containing  0.2 mM PhCH~SO~F. Flow rate was 30 ml/h. 
The glycine eluate contained predominantly low molec- 
ular weight  material. Inset: SDS-PAGE of (A) whole 
amniotic fluid, unreduced;  (B)  whole  amniotic fluid, 
reduced; (C) NaSCN eluate, unreduced; (D) NaSCN 
eluate, reduced. The positions of migration of reduced 
plasma CIG and the bromphenol blue tracking dye are 
indicated. 
SDS-PAGE of amniotic fluid after TCA precip- 
itation revealed the presence of a faint, somewhat 
heterogeneous,  reducible protein  migrating with 
an  apparent  weight  of  -240,000  daltons  after 
reduction (Fig. 3 A  and B). The band appeared to 
migrate as a  dimer or as multimers in the absence 
of  reduction.  The  protein  was  stained  by  the 
periodic acid-Schiff procedure, indicating the pres- 
ence  of  carbohydrate.  In  addition,  the  protein 
could be completely precipitated by affinity-puri- 
fied anti-CIG, as assessed by densitometric com- 
parison of parallel immune and TCA precipitates 
of amniotic fluid  after  SDS-PAGE  and  staining 
with  Coomassie  Blue  (ICI  United  States,  Inc., 
Wilmington, Del.). 
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amniotic fluid by affinity chromatography on an- 
tibody-conjugated Sepharose (Fig. 3). The eluted 
protein  was  examined,  after  dialysis,  by  SDS- 
PAGE  and  found  to  be  highly  purified  after  a 
single pass through the column (Fig. 3 C  and D). 
An  estimated  yield of  70%  was  obtained.  The 
protein has also been purified by sequential am- 
monium sulfate precipitation, and molecular sieve 
chromatography  2 or  by  affinity chromatography 
on  gelatin-Sepharose  (8).  Experiments  in  prog- 
ress, as well as the data described below, strongly 
suggest that this protein is similar, if not identical, 
to  flbronectin  isolated  from  the  cell  layer  and 
medium of cultured cells. Henceforth, the protein 
will be referred to as amniotic fluid fibronectin. 
The migration of amniotic fluid flbronectin was 
compared with that of plasma CIG under reducing 
conditions on  SDS-PAGE  (Figs. 3  and 4).  Like 
CIG,  amniotic  fluid  fibronectin  behaved  as  a 
dimer  (although  small  amounts  of  protein  mi- 
grated as a monomer in the absence of reduction). 
However, unlike CIG, which migrated as a  rela- 
tively narrow band or as a closely spaced doublet 
with a maximum apparent molecular weight after 
reduction of 220,000,  fibronectin migrated  as  a 
broad band with a  maximum apparent molecular 
weight of 240,000, and co-migrated with fibronec- 
tin  prepared  from  fetal  skin  flbroblast  cultures 
(data not shown). The upper margin of this band 
corresponded to the position of a filamin standard 
(molecular weight -250,000).  A  protein migrat- 
ing as a narrow band below the fibronectin region 
with  an  apparent  molecular  weight  of  220,000 
after reduction was occasionally noted. 
Amniotic fluid fibronectin was quantitated with 
antibodies to CIG using radioimmune  inhibition 
assays (Table I). The result, -70/zg/ml or 1.1% 
of total protein, was in good agreement with that 
reported by Chen et al. (5). The result was also in 
agreement  with  independent  estimates obtained 
by  radial  single  immunodiffusion  using  plasma 
CIG as a standard (60-70/zg/ml) and was consist- 
ent with densitometry of stained gels of amniotic 
fluid. 
Synthesis of Fibronectin by Amniotic 
Fluid Cells 
CULTURE MEOrOM:  Radial  immunodiffusion 
of  amniotic  fluid  cell  culture  medium  against 
monospecific  anti-CIG  antibodies  gave  a  single 
precipitin line which fused with that produced by 
amniotic  fluid,  amniotic  fluid  flbronectin,  and 
Fmu~  4  SDS-PAGE. Samples were reduced with 50 
mM dithiothreitol (DTT) and run  on  a composite  gel 
(3% stacking gel, 5% separating  gel, 10% lower sepa- 
rating  gel).  Gels were  stained with  0.25%  Coomassie 
Blue in methanol-acetic acid. (A) plasma CIG; (B) 20% 
(wt/vol) ammonium sulfate precipitate of amniotic fluid; 
(C)  TCA  precipitate  of  F  cell  medium;  (D)  TCA 
precipitate of AF cell medium. 
TABLE  I 
Quantitation of Second-Trimester Amniotic Fluid 
Fibronectin by Radioimmune Inhibition Assay 
Fluid, sample  ~,g of fibronee-  mg of protein*/ 
number  tin/ml of fluid  ml of fluid  % fibronectin 
1  36  4.6  0.78 
2  97  7.5  1.29 
3  66  4.8  1.38 
4  66  5.8  1.14 
5  83  6.8  1.22 
6  56  6.8  0.83 
Average  •  67 •  9  6.1 •  0.5  1.1 •  0.1 
SEM 
* Protein was measured by method of Lowry et al. (26). 
purified plasma CIG (Fig. 2). Whole FCS did not 
give a  precipitin line or modify the precipitin line 
of plasma CIG. The  immunoreactive material in 
culture  medium  also  migrated with  CIG  in  im- 
mune electrophoresis. 
A  major component of AF and F cell medium 
was  observed by SDS-PAGE  as a  polydisperse, 
reducible protein which co-migrated with amniotic 
fluid fibronectin but  migrated more  slowly than 
purified  CIG  (Fig.  4).  The  protein  was  more 
prominent in E  and AF cell medium than in F cell 
medium after loading of equal aliquots of medium 
protein. SDS-PAGE and fluorescence autoradiog- 
raphy  of  biosynthetically  radiolabeled  medium 
proteins  of E,  AF,  and  F  cells  also  revealed  a 
major band which co-migrated with the Coomas- 
sie-stained medium band and with amniotic fluid 
flbronection, both before and after reduction (Fig. 
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cipitates of cell culture  medium  proteins run  on SDS- 
PAGE. Confluent  cultures of E, AF, and F cells were 
labeled for 12 h with 20/~Ci/ml of L-[3H]amino  acids in 
the  absence  of  FCS.  The  composition  of  the  gel  is 
described in the legend to Fig. 4. Proteins were reduced 
with 50 mM DTF. 
5).  Like  amniotic fluid  fibronectin,  this  protein 
was completely precipitable by antibodies to CIG 
and  fibronectin.  The  protein  was  resistant  to 
digestion by  purified  bacterial collagenase  (data 
not  shown).  On  the  other hand,  the major high 
molecular weight  proteins  in  F  cell medium,  as 
well as the major radiolabeled bands below fibro- 
nectin in E or AF cultures, have been shown to be 
collagenous.3 
In medium from confluent cultures of E  or AF 
cells, labeled in the presence of ascorbate for 12- 
24  h  with  [3H]tyrosine,  [3H]proline,  or  with 
3H-amino  acids, fibronectin constituted 40-50% 
of  the  radioactivity as  determined  by  immune 
titration  using  anti-fibronectin  or  anti-CIG  sera 
(Fig. 6). Quantitation of fibronectin by densitom- 
etry of fluorescence autoradiographs, or by mea- 
surement of the distribution of radioactivity after 
affinity chromatography on  antibody- or gelatin- 
conjugated  Sepharose,  gave  comparable  results. 
Fibronectin was  a  comparatively minor  compo- 
nent of fibroblast or F cell cultures, accounting for 
10-25%  of the total radioactivity of the medium. 
These data were supported by radioimmune inhi- 
bition analysis of fibronectin accumulating in the 
medium of cells cultured in DMEM in the absence 
of serum  for a  24-h  period. E  cell cultures con- 
tained 29  /zg of fibronectin per mg of cell layer 
protein;  comparable  values  for  AF cells  and  F 
3 Crouch,  E., and P. Bornstein.  Manuscript in prepara- 
tion. 
cells were  24  /zg and  13  /zg, respectively. How- 
ever, the proportion of radioactivity in fibronectin 
and the total incorporation into this protein could 
be  significantly  modified  by  the  conditions  of 
culture. The proportion of fibronectin in the me- 
dium  was  increased  at  low  cell densities and  in 
cultures from which ascorbate was omitted. 
Metabolic labeling with radioactive sugars (see 
below) indicated that the fibronectin synthesized 
by  amniotic  fluid  cells  is  a  glycoprotein.  The 
protein could also be  bound  to concanavalin A- 
Sepharose and subsequently eluted with a-methyl- 
D-glucopyranoside. 
The  basis  for  the  observed  polydispersity of 
fibronectin on gels was investigated. The fibronec- 
tin band appeared broad from the earliest times in 
pulse-chase experiments, and its appearance was 
not altered by the inclusion of trasylol, an inhibitor 
of serine proteases, in the labeling medium. Inas- 
much as heterogeneity in the extent of glycosyla- 
tion may account for polydispersity on SDS gels, 
E  or AF cultures were labeled with D-[2-3H]man  - 
nose  or  D-[6-aH(N)]glucosamine  and  [14C]pro- 
line. The culture medium was then immune-pre- 
cipitated with anti-CIG serum, and the precipitate 
was run on 4%  SDS-PAGE to maximize resolu- 
tion  of the  fibronectin band.  The  protein  band 
(after  localization  by  fluorescence  autoradiog- 
raphy)  was  sliced  horizontally.  Quantitation  of 
the  amount  of aH  relative  to  1~C  in  each  slice 
indicated  that  the  upper  regions  of  the  broad 
band  were  enriched  in  carbohydrate relative to 
the  more  rapidly migrating regions of the  band 
(Fig.  7).  Although  distinct  bands  were  not  re- 
5C 
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/J.l  of  Robbit  Anti-Human  CIG  ~rum 
FIGURE 6  Immune  precipitation of labeled amniotic 
fluid cell culture media with anti-CIG serum. A double- 
antibody assay was used  (see Materials and Methods). 
Confluent  cultures  of AF, E, and F cells were  labeled 
with 20  txCi/ml of [3H]tyrosine in the absence of FCS. 
(11) AF cell medium,  (O) E  cell medium, (A) F cell 
medium. 
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Fmul~  7  Relative carbohydrate content  of AF cell 
culture medium fibronectin. Cells were labeled for 24 h 
with  0-[2-SH]mannosc  and  L-[14C]proline  or  0-[6- 
8H]glucosamine and  L-[14C]proline. The  medium  was 
dialyzed  against  Tris-saline,  and  1  ml,  containing 
-12,000  clam of  x4C  and  79,000  cpm  of  3H,  was 
precipitated  using  afftnity-purifled  anti-CIG  IgG  and 
sheep anti-rabbit IgG antiserum. The precipitate  was run 
on SDS-PAGE using a 4% separating gel. The fibronec- 
tin band was identified by fluorescence autoradiography 
and was cut horizontally in 2-mm slices from the dried 
gel. Hydrolysis and paper chromatography  of immune 
precipitates  labeled with mannose  alone indicated  that 
the  label was  present in  mannose  (78%)  and  fucose 
(23%). Similarly, ion-exchange chromatography  of im- 
mune  precipitates labeled with  glucosamine  indicated 
that label was present in glucosamine (68%) and galac- 
tosamine  (27%).  No  tritium  label  was  recovered  in 
amino acids. 
solved,  we  cannot  exclude  the  presence  of  a 
limited number of closely spaced protein chains. 
CELL LAIR:  Fibronectin  has  been  demon- 
strated in the cell layers of cultured amniotic fluid 
cells by several techniques. Immune precipitation 
of biosynthetically labeled cell layer proteins after 
extraction with urea (43), chaotropic agents (19), 
or  1%  Triton X-100  (Rohm  &  Haas Co.,  Phila- 
delphia,  Pa.)  in  sodium  phosphate,  pH  11  (33) 
quantitatively precipitated a  protein migrating in 
the  region  of medium  fibronectin  (Fig.  8).  The 
corresponding Coomassie Blue-staining band of E 
or AF cells constituted  at  least 3%  of the  total 
stained protein in 72-96 h cultures and was sensi- 
tive to trypsinization (data not shown). A  reduci- 
ble protein, migrating as fibronectin on SDS gels, 
was identified in the cell layers of amniotic fluid 
cells by lactoperoxidase-catalyzed  iodination (Fig. 
9a). Fibronectin was also identified in association 
with amniotic fluid cells in culture by fluorescence 
labeling  with  affinity-purified rabbit  anti-human 
CIG  and FITC-conjugated goat anti-rabbit IgG. 
E  and  AF cells stained more  intensely than  did 
corresponding F cultures. Fig. 9b shows a labeled 
E  cell  and  illustrates the  characteristic reticular 
staining pattern. Fluorescence staining was largely 
absent after incubating the cells in situ  with tryp- 
sin-TPCK (5  /xg/ml for  10-15  min at room tem- 
perature) or after preabsorption of the first anti- 
body  with  purified  CIG.  The  staining  was  not 
altered by preabsorption of the first antibody with 
FCS. 
AF cell cultures were reacted with affinity-puri- 
fied  anti-CIG  and  ferritin-conjugated goat  anti- 
rabbit IgG and  studied by transmission electron 
FmURE  8  Fluorescence  autoradiographs  of  culture 
medium  and  cell  layer proteins  run  on  SDS-PAGE 
before  and after immune  precipitation. Confluent  cul- 
tures of AF cells were labeled for 24 h as described in 
legend to Fig. 5. The cell layer was extracted for 15 min 
with 1 M urea in DMEM, pH 7.4, containing 0.5 mM 
PhCH2SOzF. The  cells were  then  homogenized  in  50 
mM sodium  phosphate, pH  11, containing  1%  Triton 
X-100 (33). The homogenate was centrifuged for 1 h at 
27,500 g and the supemate dialyzed against Tris-saline 
containing 0.1% Triton X-100 in the presence of inhibi- 
tors.  (A)  urea  extract of cell  layer precipitated with 
TCA; (B) Triton X-100 extract of cell layer precipitated 
with  TCA;  (C)  medium  precipitated with  anti-CIG 
serum  and  sheep antirabbit IgG antiserum;  (D)  urea 
extract  of cell layer precipitated with  anti-CIG serum 
and sheep anti-rabbit IgG antiserum;  (E) Triton X-100 
extract  of cell layer precipitated with  anti-CIG serum 
and sheep anti-rabbit IgG antiserum.  All samples were 
reduced with DTT. 
'708  THE  JOURNAL  OF  CELL  BIOLOGY"  VOLUME  78, 1978 FIGURE 9  (a)  Fluorescence autoradiographs  of lacto- 
peroxidase-catalyzed iodinated proteins in cell layers run 
on SDS-PAGE. (A) AF cell layer, reduced; (B) AF cell 
layer, unreduced;  (C) F cell layer, reduced;  (D) F cell 
layer, unreduced. The position of migration of a reduced 
CIG marker is indicated. 
microscopy. In transverse  sections, a  filamentous 
ferritin-labeled  matrix  was  commonly  observed 
directly adjacent to the cell membrane, frequently 
in association with underlying microfilaments (Fig. 
10a).  Labeled  antibody  was  absent  from  the 
plasma membrane at sites without associated (per- 
icellular) matrix. The labeled matrix was observed 
to contain three  morphologically distinct compo- 
nents:  fine  filaments  (50  A),  larger  periodically 
banded,  presumably collagenous filaments  (150- 
175 A), and a diffuse, amorphous substance that 
formed  a  fine  reticulum.  The  fine  filaments  ap- 
peared  continuous  with  intracellular  microfila- 
ments (Fig.  10b), but this effect probably results 
from the close apposition of intra- and extracellu- 
lar filaments  in similar orientations.  The specific 
matrix component that was labeled was not iden- 
tified morphologically; however, ferritin appeared 
to be associated with the  diffuse nonfilamentous 
material  in instances  where  the  plane  of section 
grazed the matrix surface tangentially. It was clear 
that the banded filaments had no selective affinity 
for the antibody. No ferritin labeling was observed 
when  affinity-purified  anti-CIG  IgG was  preab- 
sorbed with CIG (Fig. 10c). 
SECRETION  OF  FmRONECTIN:  In pulse-chase  ex- 
periments,  >50%  of the  fibronectin  synthesized 
by AF cells  appeared in the medium by 2-4 h of 
chase  and  >70%  appeared  by  8  h  (Fig.  11a). 
Subsequently,  the  amount  of fibronectin  in  the 
culture remained  relatively constant over a  48-h 
period. The fibronectin remaining in the cell layer 
after several hours of chase was exclusively local- 
ized at trypsin-sensitive sites  and had an apparent 
half-life of 2 days (data not shown). There was no 
significant redistribution of fibronectin beyond the 
first  few  hours  after  synthesis.  The  amount  of 
fibronectin  in  the  medium  was  not  appreciably 
altered  by  the  presence  of  serum  in  the  chase 
medium or by trypsinization of cells in situ  12 h 
before  the  labeling.  We  presently  have  no  evi- 
dence for time-dependent conversion, in culture, 
of fibronectin to a  molecule with the mobility of 
CIG. 
The maximum synthesis and secretion time of 
fibronectin  into  the  medium  of  AF  cells  was 
estimated  to  be  -90  min  by  quantitating  the 
amount of immune precipitable fibronectin in the 
medium  after  2,  3,  and  4  h  of continuous label 
incorporation and extrapolation  to zero incorpo- 
ration  (Fig.  l lb).  In  parallel  experiments,  the 
minimum transit time to trypsin-sensitive sites was 
estimated  to  be  45-60  min  by  comparing  the 
amount of radiolabeled fibronectin in trypsinized 
vs.  nontrypsinized  cell  layers  (data  not  shown). 
On the basis  of these  experiments,  we conclude 
that the majority of newly synthesized AF fibro- 
nectin has, at most, a short half-life in association 
with  the cell layer.  It is more likely that  a  large 
fraction of fibronectin is secreted directly into the 
culture medium. 
DISCUSSION 
The studies described here establish the presence 
of a  protein  immunologically related  to  CIG in 
second-trimester human amniotic fluid. The pro- 
tein migrates more slowly and heterogeneously on 
SDS-PAGE  than  plasma  CIG  but  co-migrates 
with  the  fibronectin  synthesized  by  fetal  skin 
fibroblasts in culture. E, AF, and F synthesize and 
release  into  the  culture  medium  a  protein  with 
comparable properties.  This protein  satisfies  the 
major  analytical  criteria  for  its  identification  as 
fibronectin: (a) cross-reaction with anti-CIG anti- 
bodies  (36),  (b) a  molecular weight after reduc- 
tion  of  -230,000  (16),  (c)  interchain  disulfide 
bonds  (22),  (d)  covalently  linked  carbohydrate 
(16),  (e)  labeling  by  lactoperoxidase-catalyzed 
iodination  of cell  layers  (15,  16),  (f)  a  reticular 
cell-surface  associated  immunofluorescence  pat- 
tern (2,  37, 42),  and (g) rapid release from cell- 
associated sites by trypsin (15). 
The  striking  electrophoretic  polydispersity  of 
fibronectin, in the absence of evidence for limited 
CROUCH, BALIAN, HOLBROOK, DUKStN, AND BORNSTEn~ Amniotic Fluid Fibronecfin  709 FIGURE 9  (b)  Surface immunofluorescence pattern of an E cell stained with affinity purified rabbit anti- 
human CIG IgG and FITC-conjugated  goat antirabbit IgG. x  860. 
proteolytic degradation, suggests heterogeneity in 
the  type or extent of glycosylation. We have,  in 
fact, demonstrated variations in the carbohydrate 
content  of  fibronectin  secreted  by  AF  cells  in 
culture  (Fig.  7).  Whether  these  differences can 
account for the observed differences in migration 
remains to be determined. Although Vuento et al. 
(39)  concluded  that  fibroblast  fibronectin  and 
plasma CIG are probably identical, other investi- 
gators  have  observed  differences  in  electropho- 
retic migration between fibronectin and CIG (22, 
31). Furthermore, the proteins may differ in their 
solubility at neutral pH (45) and in their biological 
activity (17). 
The structural basis for the observed differences 
between  amniotic  fluid  fibronectin  and  CIG  is 
currently under investigation. Although fibronec- 
tin showed complete immunologic cross-reactivity 
with plasma CIG using antibodies to CIG, specific 
chemical  and  enzymatic  cleavage  has  indicated 
discrete  differences  between  the  two  proteins.  2 
Nevertheless, the overall immunologic and struc- 
tural  similarity of fibronectin  and  CIG  strongly 
suggests that they are homologous gene products. 
Although we have not obtained evidence in these 
studies  for  the  conversion  of  fibronectin  to  a 
protein with the mobility of CIG in culture, fibro- 
nectin  may be  a  precursor of CIG.  Conversion, 
possibly by limited proteolysis and/or modification 
of the carbohydrate, may occur only in plasma or 
in another location in vivo. The recent observation 
that  endothelial cells synthesize and secrete sub- 
stantial  amounts  of  fibronectin  in  culture  (H. 
Sage  and  P.  Bornstein.  Unpublished  observa- 
tions) suggests that these cells may function  as a 
source of plasma CIG. 
In view of the original characterization of fibro- 
nectin  as  a  cell  surface  antigen  (37)  or  surface 
protein  (43,  44),  it  is  worthwhile  to  consider 
whether differences also exist between cell-associ- 
710  ThE  JOURNAL  OF  CELL  BIOLOGY ￿9  VOLUME  78, 1978 FIGURE 10  (a) Border of an AF cell in cross-section, showing intracellular microfilaments (IF), plasma 
membrane, and pericellular matrix (M). The matrix is labeled with affinity-purified anti-CIG IgG and 
ferritin-conjugated goat anti-rabbit IgG. Arrows indicate ferritin labeling, x  85,000. (b) Border of an AF 
cell sectioned en  face,  showing pericellular matrix labeled with affinity-purified anti-CIG and ferritin- 
conjugated goat anti-rabbit IgG. Note that label is located in the pericellular matrix, including regions 
lacking filaments. Arrows indicate ferritin labeling, x  33,750.  (c) Border of an AF cell and associated 
pericellular matrix from a control preparation. None of the matrix components are labeled with ferritin. 
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FIGURE 11  (a) Pulse-chase experiment. Confluent AF 
cells were labeled for 30 rain with [3H]tyrosine, rapidly 
rinsed three times with DMEM, and chased for up to 48 
h  in  serum-free  DMEM.  Equal  aliquots  of  culture 
medium and cell layer were precipitated with TCA and 
analyzed by SDS-PAGE under reducing conditions. The 
fibronectin  band  was  quantitated  by  densitometry  of 
fluorescence  autoradiograms.  (11) cell  layer plus me- 
dium,  (&)  medium,  (e)  cell  layer.  (b)  Kinetics  of 
isotope incorporation  into fibronectin in AF cell culture 
medium.  Confluent  cell  cultures  were  labeled  with 
[aH]tyrosine in serum-free medium. Under these condi- 
tions, incorporation into medium protein was linear from 
2 to 24 h. At 2, 3, and 4 h after the start of labeling, 
replicate aliquots  of culture  medium  were  precipitated 
with anti-CIG serum and sheep anti-rabbit IgG antise- 
rum. 
ated and culture-medium (or amniotic fluid) fibro- 
nectins.  Yamada  et  al.  (33,  44)  have  proposed 
that  medium  fibronectin  represents  a  "variably 
sloughed" cell surface protein. This view may be 
consistent  with  the  observation  that  -80%  of 
newly  synthesized  chick  cell-surface protein  re- 
mains associated with the cell layer and turns over 
with a  t1/2 of 36 h  (33). However, amniotic fluid 
cells  and  human  lung  fibroblasts  (1)  rapidly 
release  a  large  proportion of newly synthesized 
fibronectin into the culture medium. As described 
above,  the maximum time for the synthesis and 
release of fibronectin into the medium of cultured 
AF cells is only slightly longer than the minimum 
transit time for the appearance of fibronectin at 
trypsin-sensitive sites on  the  cell surface.  These 
results  differ  from  the  turnover  rates  for  bulk 
membrane proteins, which have been reported to 
be on the order of 24 h for nongrowing cells (40), 
although a membrane-associated protein involved 
in dynamic processes such as cell motility and cell- 
substratum  interactions  might  turn  over  more 
rapidly  than  other  membrane  components.  Ki- 
netic  data  describing the  release  of fibronectin 
are, however, similar to those obtained for procol- 
lagen, a secreted protein which is incorporated as 
collagen into extracellular matrix  (20,  24).  The 
relationship of the rapidly secreted fibronectin to 
that which remains associated with the cell layer is 
currently under investigation. 
We have localized fibronectin to the extraceilu- 
lar  and  pericellular matrix  of cultured  amniotic 
fluid  cells by  ferritin-labeling studies  (Fig.  10); 
similar results were recently reported for rat myo- 
blasts studied with the peroxidase-anti-peroxidase 
method (9). These results are consistent with the 
extracellular distribution of fibronectin in connec- 
tive tissues and basement membranes as detected 
by immunofluorescence  (25,  41),  with  the  pub- 
lished observations of collgen-fibronectin interac- 
tions  (8),  and  with  the  kinetic  data  presented 
above.  Thus,  culture  medium  fibronectin  may 
represent the portion of secreted protein that fails 
to be incorporated into an insoluble matrix. In this 
respect, the medium in tissue culture may be an 
approximation of amniotic fluid in vivo. In both 
instances, the cells are directly exposed to a large 
fluid  compartment,  unlike  the  more  restricted 
environment  of  cells  within  most  tissues.  We 
therefore suggest that amniotic fluid fibronectin is 
the  same  protein that  elsewhere  in  the  body  is 
incorporated into basement membranes and other 
connective tissues. For this reason, amniotic fluid 
may serve as a  convenient source of fibronectin 
for further  structural  and  biological studies.  We 
are  presently  evaluating  the  ability of amniotic 
fluid fibronectin to mediate  cell attachment  and 
alter the behavior and morphology of transformed 
cells. 
Relatively few amniotic fluid proteins have been 
shown to be synthesized within the fetal amniotic 
fluid compartment.  Most  proteins appear  to  be 
distributed between plasma and amniotic fluid in 
a manner consistent with a mechanism of passive 
diffusion  (38).  However,  our  data  suggest  that 
fibronectin is synthesized and accumulates within 
the  fetal  amniotic  space.  Quantitation  of  the 
amount of fibronectin .in amniotic fluid (Table I) 
clearly indicates that  there  is  an  enrichment  of 
protein, recognized by anti-CIG antisera, in am- 
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amniotic fluid fibronectin and plasma CIG may be 
distinguished by analytical criteria. It is of interest 
that  recent  studies  by  Wartiovaara  et  al.  (41) 
suggest  that  cells  lining  the  proamniotic  cavity 
express  the  synthesis  of fibronectin during  early 
embryonic development. Amniotic fluid fibronec- 
tin  may therefore  be  a  marker for the  synthetic 
and secretory activity of fetal cells. 
Although the amniotic fluid cells described here 
were  cloned  and  therefore  represent  a  highly 
selected population,  preliminary studies on mass 
cell  cultures  and  biosynthetically  labeled  whole 
fluid suggest that such cells could make a contri- 
bution  to the pool of amniotic fluid fibronectin. 
The relative abundance of epithelioid (E and AF) 
cells  suggests that these cells would play a  more 
prominent synthetic role than amniotic fluid fibro- 
blasts (F cells). It should be noted that the major- 
ity of cells  in  amniotic fluid  cannot be  cultured 
and are ultrastructurally distinct from E, AF, or F 
cells.  These  cells,  although  frequently viable  by 
the  criterion  of dye  exclusion,  appear  to  be  of 
epidermal origin on the basis of their ultrastruc- 
ture  and  probably do not synthesize  fibronectin 
(E. Crouch and K. Holbrook. Unpublished obser- 
vations).  Cells  of the  amnion,  however,  could 
make  a  significant  contribution  to  the  pool  of 
fibronectin.  We  have  recently  observed  that 
epithelioid  cells  explanted  from  fetal  amnion 
synthesize  and  secrete  a  fibronectin-like  protein 
that  is precipitable  by antibodies  to CIG.  How- 
ever,  the  migration  of  this  protein  appeared 
to be slower than that observed for amniotic fluid 
cells. The relationship of this protein to amniotic 
fluid fibronectin is currently under investigation. 
Possible  contributions  by  other  fetal  cells  (gas- 
trointestinal  tract,  lung,  and  urinary  tract)  also 
remain to be evaluated. 
Amniotic fluid cells are of fetal origin, as dem- 
onstrated  by  karyotype  analysis  (13),  but  their 
tissue of derivation is unknown. These cells could 
be  derived  from any tissue  in  direct  or indirect 
continuity with the amniotic cavity. Only very rare 
clones of cells isolated from amniotic fluid have a 
morphology similar to that of cells isolated from 
the amnion. However, cells morphologically and 
behaviorally indistinguishable from E and AF cells 
have  been  isolated  from  second-trimester  fetal 
urine  (12),  and very similar  cells can  be cloned 
from  fetal  kidney  (12).  Furthermore,  clonable 
epithelioid  cells  are  most  readily  isolated  from 
amniotic fluid at  16-20 wk gestation,  which ap- 
proximates  the  time  when  fetal  urine  begins  to 
make a  significant contribution to amniotic fluid 
(38). Whether there are corresponding variations 
in  the  amount  of fibronectin  in  amniotic  fluid 
during the course of gestation  is currently being 
investigated. 
The studies presented here deafly indicate that 
epithelial  cells  synthesize  and  accumulate  fibro- 
nectin. However, as noted above, the embryologic 
derivation of these  epithelial  cells  is not known. 
Chen et al. (6) recently described the synthesis of 
fibronectin by epithelioid cell lines isolated from 
rat liver and baby hamster kidney, but the identi- 
fication  of  the  cells  was  based  only  on  their 
appearance  in  the  light  microscope.  Amniotic 
fluid  E  cells, on the other hand,  form complete 
desmosomal complexes in regions of cell-cell  con- 
tact and can therefore be defined as epithelial cells 
on ultrastructural  grounds: Furthermore,  E  cells 
remain euploid and continue to express the nor- 
mal phenotype until  passaged to senescence, un- 
like rat and hamster epithelial cells, which tend to 
become established cell lines (6). 
In summary,  we  have  shown  that  fibronectin 
accumulates  in  amniotic fluid  and  have  demon- 
strated that fetal cells derived from this compart- 
ment synthesize and secrete fibronectin in culture. 
We have also presented preliminary evidence that 
amniotic  fluid  fibronectin  is  electrophoretically 
distinct from plasma CIG. On the basis of these 
findings, we conclude that amniotic fluid fibronec- 
tin  is  a  fetal  protein  synthesized  by  fetal  cells 
within the amniotic fluid compartment and antici- 
pate  that  this  protein  may  prove  useful  as  a 
marker, accessible to amniocentesis, of fetal pro- 
tein  synthetic  activity  and  tissue  differentiation. 
Amniotic fluid should also be a convenient source 
of fibronectin for further structural and biological 
studies. In addition, we have shown that fibronec- 
tin accumulates in the extracelhilar and pericellu- 
lar matrix  of cultures of amniotic fluid cells  and 
have  presented  kinetic  data  that  are  consistent 
with  a  role  for flbronectin  as  a  secreted  matrix 
protein. 
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